No Increase of β2-Glycoprotein I Levels in Patients with Antiphospholipid Antibodies

REFERENCES
1 Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda-Vriesman PJC, Barbui T, Zwaal RFA, Bevers EM. Anticar-diolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335: 1544-1547
2 McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Anti-phos-pholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β₂-glycoprotein I (Apolipo-protein H). Proc Natl Acad Sci. 1990; 87: 4120-4124
3 Bevers EM, Galli M. β₂-glycoprotein I for binding of anticardiolipin antibodies to cardiolipin. Lancet. 1990; 336: 952-953
4 Koike T, Matsuura E. What is the “true” antigen for anticardiolipin antibodies? Lancet. 1991; 337: 671-672
5 Galli M, Cortelazzo S, Daldossi M, Barbui T. Increased levels of β₂-glycoprotein I (aca-cofactor) in patients with lupus anticoagulant. Thromb Haemostas 1992; 67: 386
6 McNeil HP, Hunt JE, Krilis SA. New aspects of anticardiolipin antibodies. Clin Exp Rheumatol 1990; 8: 525-527
7 Reber G, Roisin J-P, Vogel J-J, Martinoli J-L, de Moerloose P. An improved platelet neutralization procedure as confirmatory test for the presence of lupus anticoagulant. Thromb Haemostas 1991; 65: 1103 (abstr)
8 Reber G, Tremblet C, Bernard C, Mermillod B, de Moerloose P. Anticardiolipin antibodies and thrombosis: buffer's influence on the detection and quantitation of anticardiolipin antibody measured by ELISA. Thromb Res 1990; 57: 215-226
9 Oosting JD, Derksen RHWM, Entjes HT, Bouma BN, de Groot PG. Lupus anticoagulant activity is frequently dependent on the presence of β₂-glycoprotein I. Thromb Haemostas. 1992; 67: 499-502